Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PYC.AU
- Price
- 0.99
- Stock movement down
- -0.06 (-5.69%)
- Company name
- PYC Therapeutics Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 466.82M
- Ent value
- 410.13M
- Price/Sales
- 11.51
- Price/Book
- 5.76
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -10.88%
- 1 year return
- 8.74%
- 3 year return
- 2.13%
- 5 year return
- 4.81%
- 10 year return
- 24.37%
Last updated: 2025-04-10
DIVIDENDS
PYC.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.51 |
| Price to Book | 5.76 |
| EV to Sales | 10.11 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 469.16M |
| EPS (TTM) | -0.01 |
| FCF per share (TTM) | -0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 40.56M |
| Gross profit (TTM) | 40.13M |
| Operating income (TTM) | -69.83M |
| Net income (TTM) | -47.55M |
| EPS (TTM) | -0.01 |
| EPS (1y forward) | -0.01 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 98.94% |
| Operating margin (TTM) | -172.16% |
| Profit margin (TTM) | -117.23% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 66.87M |
| Net receivables | 18.00M |
| Total current assets | 85.61M |
| Goodwill | 0.00 |
| Intangible assets | 4.05M |
| Property, plant and equipment | 5.59M |
| Total assets | 91.24M |
| Accounts payable | 7.53M |
| Short/Current long term debt | 1.11M |
| Total current liabilities | 9.11M |
| Total liabilities | 10.18M |
| Shareholder's equity | 81.05M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -57.40M |
| Capital expenditures (TTM) | 828.68K |
| Free cash flow (TTM) | -58.23M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -58.67% |
| Return on Assets | -52.12% |
| Return on Invested Capital | -58.44% |
| Cash Return on Invested Capital | -71.57% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.03 |
| Daily high | 1.04 |
| Daily low | 0.97 |
| Daily Volume | 702K |
| All-time high | 6.47 |
| 1y analyst estimate | 8.70 |
| Beta | 0.60 |
| EPS (TTM) | -0.01 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PYC.AU | S&P500 | |
| Current price drop from All-time high | -84.62% | -10.49% |
| Highest price drop | -98.63% | -56.47% |
| Date of highest drop | 13 Aug 2014 | 9 Mar 2009 |
| Avg drop from high | -84.29% | -11.07% |
| Avg time to new high | 238 days | 12 days |
| Max time to new high | 4271 days | 1805 days |
COMPANY DETAILS
Marketcap
466.82M
Marketcap category
Small-cap
Description
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program which is Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for the treatment of blinding eye disease; PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder; and PYC-003, which is indicated to treat autosomal dominant polycystic kidney disease. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found